Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6193982

Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a m

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194176

Recombinant expression of proteins from secretory cell lines

The Board of Regents of the University of Texas System · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194206

Use of oligonucleotide telomerase inhibitors to reduce telomere length

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194390

Procedure to block the replication of reverse transcriptase dependent viruses by the use o

expired patent

US 6194419

Nitrogen-containing heterocyclic compounds, their production and use

Takeda Chemical Industries Ltd. · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194421

Inhibitors of metazoan parasite proteases

The Regents of the University of California · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194450

Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194460

Composition for treating cough induced by angiotensin converting enzyme inhibitors

Montefiore Medical Center · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194481

Mechanically strong and transparent or translucent composites made using zirconium oxide n

expired patent

US 6194547

ETS2 repressor factor (ERF)

expired patent

US 6194557

Nucleic acid molecules encoding Bap-1 proteins

COR Therapeutics, Inc. · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6193949

Method of sire selection using naloxone challenge tests and kits thereof

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6193963

Method of treating tumor-bearing patients with human plasma hyaluronidase

The Regents of the University of California · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6193965

Oncoprotein kinase

The Regents of the University of California · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6191147

Pyrazole compounds and uses thereof

PPD Discovery, Inc. · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6191107

Complex of human growth hormone and zinc

Takeda Chemical Industries Ltd. · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6191103

Methods for enhancing thrombolysis in a mammal

The Regents of the University of California · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190894

Method and compositions for disrupting the epithelial barrier function

The Regents of the University of California · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190859

Method and kit for detection of dengue virus

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190723

Neutralization of food allergens by thioredoxin

The Regents of the University of California · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190702

Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil pha

Takeda Chemical Industries Ltd. · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190700

Production of sustained-release preparation for injection

Takeda Chemical Industries Ltd. · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190695

Pharmaceutical composition containing osteogenesis-promoting substance

Takeda Chemical Industries Ltd. · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190656

Immunologic enhancement with intermittent interleukin-2 therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired